Skip to content
stockresearch.app
BMY/History

Bristol Myers Squibb (BMY) valuation history

Within its usual range

As of

BMY's EV/EBITDA of 9.4x is lower than 60% of its available weekly readings from the last five years.

EV/EBITDA weekly history0.8×20.3×39.9×59.4×Shading: 5-year middle halfMedian 9.7×9.4×202120232025
Share EV/EBITDA history
Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/EBITDA at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

BMY year-end valuation history
Reading dateEV/EBITDA5-year rank
9.5×43%
30.9×94%
6.9×3%
9.6×10%
21.2×86%
12.1×16%
12.3×16%
12.9×0%
15.9×15%
20.2×25%

Loading related research…

About this history

What is BMY's current EV/EBITDA?
BMY's EV/EBITDA of 9.4x is lower than 60% of its available weekly readings from the last five years.
What is BMY's five-year median EV/EBITDA?
The median, or middle weekly reading, is 9.7× over the last five years. Available history contains 860 weekly observations from May 3, 2010 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Source: SEC company filings and weekly market prices. Multiples use the previous twelve months of financial results. Updated .

Read the valuation methodology